Log in

TSE:KXSKinaxis Stock Price, Forecast & News

+0.61 (+0.29 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: C$208.96
50-Day Range
MA: C$183.75
52-Week Range
Now: C$208.96
Volume92,050 shs
Average Volume123,709 shs
Market CapitalizationC$5.54 billion
P/E Ratio257.98
Dividend YieldN/A
Kinaxis Inc. provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. The company offers RapidResponse, which provide supply chain planning and analytics capabilities for managing various supply chain management processes, including demand planning, supply planning, inventory management, order fulfillment, capacity planning, and master scheduling, as well as sales and operations planning process. It also provides professional services, such as implementation, technical, and training services, as well as maintenance and support services to its software products. The company serves enterprises operating in various industries, including aerospace and defense, automotive, consumer products, high tech and electronics, industrial, life sciences, and pharmaceuticals. The company was formerly known as webPLAN Inc. and changed its name to Kinaxis Inc. in May 2005. Kinaxis Inc. was founded in 1984 and is headquartered in Ottawa, Canada.
Read More
Kinaxis logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.78 out of 5 stars

Industry, Sector and Symbol

Industry Software - Application



Sales & Book Value

Annual SalesC$198.55 million
Cash FlowC$9.11 per share
Book ValueC$9.22 per share



Market CapC$5.54 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive KXS News and Ratings via Email

Sign-up to receive the latest news and ratings for KXS and its competitors with MarketBeat's FREE daily newsletter.

Kinaxis (TSE:KXS) Frequently Asked Questions

How has Kinaxis' stock been impacted by COVID-19 (Coronavirus)?

Kinaxis' stock was trading at C$111.73 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, KXS stock has increased by 87.0% and is now trading at C$208.96. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Kinaxis?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kinaxis in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Kinaxis.

When is Kinaxis' next earnings date?

Kinaxis is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Kinaxis.

How were Kinaxis' earnings last quarter?

Kinaxis Inc (TSE:KXS) issued its quarterly earnings results on Wednesday, May, 6th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.03. The company earned $70.82 million during the quarter, compared to the consensus estimate of $66.23 million. View Kinaxis' earnings history.

What price target have analysts set for KXS?

5 brokerages have issued 12 month price targets for Kinaxis' stock. Their forecasts range from C$115.00 to C$250.00. On average, they expect Kinaxis' share price to reach C$190.27 in the next twelve months. This suggests that the stock has a possible downside of 8.9%. View analysts' price targets for Kinaxis.

Has Kinaxis been receiving favorable news coverage?

Press coverage about KXS stock has been trending somewhat negative on Saturday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Kinaxis earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Kinaxis.

Who are some of Kinaxis' key competitors?

What other stocks do shareholders of Kinaxis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kinaxis investors own include Shopify (SHOP), Toronto-Dominion Bank (TD), Alimentation Couche-Tard (ATD.B), CCL Industries (CCL.B), Open Text (OTEX), Bank of Nova Scotia (BNS), Costco Wholesale (COST), NVIDIA (NVDA), Western Forest Products (WEF) and Altagas (ALA).

Who are Kinaxis' key executives?

Kinaxis' management team includes the following people:
  • Mr. John Ernest Sicard, CEO, Pres & Director (Age 56)
  • Mr. Richard George Monkman, CFO, VP of Corp. Services & Corp. Sec.
  • Mr. David Kelly, Exec. VP of Professional Services
  • Mr. Paul Z. Carreiro, Chief Revenue Officer
  • Mr. Duncan Klett, Co-Founder

What is Kinaxis' stock symbol?

Kinaxis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KXS."

How do I buy shares of Kinaxis?

Shares of KXS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Kinaxis' stock price today?

One share of KXS stock can currently be purchased for approximately C$208.96.

How big of a company is Kinaxis?

Kinaxis has a market capitalization of C$5.54 billion and generates C$198.55 million in revenue each year. Kinaxis employs 569 workers across the globe.

What is Kinaxis' official website?

The official website for Kinaxis is www.kinaxis.com.

How can I contact Kinaxis?

Kinaxis' mailing address is 700 Silver Seven Rd, KANATA, ON K2V 1C3, Canada. The company can be reached via phone at +1-613-5925780.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.